Patients with advanced chronic kidney disease (CKD), especially those on long-term dialysis, often suffer from muscle wasting and excessive fatigue. It is known that inactivity, muscle wasting and reduced physical functioning are associated with increased mortality in CKD. Known causes include uraemic myopathy and neuropathy, inactivity, and anaemia. Exercise in patients receiving regular dialysis treatment for end-stage renal disease was first introduced 3 decades ago, but is still only offered in a minority of renal units around the world, despite a significant body of evidence to support its use. Work is needed to increase awareness of the potential benefits of increased physical activity for patients with advanced CKD. This review summarizes the mechanisms of exercise intolerance and debility in advanced CKD patients, the methods used for the estimation of functional capacity, the options currently available for exercise training, and their influence on the well-being of this group of patients.

Keywords:
Exercise, Rehabilitation, Endurance, Resistance, Renal failure, Haemodialysis, Chronic kidney disease
1.
UK Renal Registry: 9th Annual Report 2006. Bristol, UK Renal Registry, 2006.
2.
Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005;293:1737–1745.
3.
McIntyre CW, Selby NM, Sigrist M, Pearce LE, Mercer TH, Naish PF: Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant 2006;21:2210–2216.
4.
Johansen KL, Doyle J, Sakkas GK, Kent-Braun JA: Neural and metabolic mechanisms of excessive muscle fatigue in maintenance hemodialysis patients. Am J Physiol Regul Integr Comp Physiol 2005;289:805–813.
5.
Beasley CR, Smith DA, Neale TJ: Exercise capacity in chronic renal failure patients managed by continuous ambulatory peritoneal dialysis. Aust NZ J Med 1986;16:5–10.
6.
Sietsema KE, Amato A, Adler SG, Brass EP: Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 2004;65:719–724.
7.
Stenvinkel P, Barany P, Chung SH, Lindholm B, Heimbürger O: A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002;17:1266–1274.
8.
Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003;14:2366–2372.
9.
Honda H, Qureshi AR, Axelsson J: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007;86:633–638.
10.
Ting SM, Nair H, Ching I, Taheri S, Dasgupta I: Overweight, obesity and chronic kidney disease. Nephron Clin Pract 2009;112:121–127.
11.
Joshi SB: Exercise training in the management of cardiac failure and ischaemic heart disease. Heart Lung Circ 2007;16:83–87.
12.
Pang MY, Eng JJ, Dawson AS, Gylfadóttir S: The use of aerobic exercise training in improving aerobic capacity in individuals with stroke: a meta-analysis. Clin Rehabil 2006;20:97–111.
13.
Bulmer AC, Coombes JS: Optimising exercise training in peripheral arterial disease. Sports Med 2004;34:983–1003.
14.
Zuwallack R: The nonpharmacologic treatment of chronic obstructive pulmonary disease: advances in our understanding of pulmonary rehabilitation. Proc Am Thorac Soc 2007;4:549–553.
15.
Ram FS, Robinson SM, Black PN, Picot J: Physical training for asthma. Cochrane Database Syst Rev 2005;19:CD001116.
16.
Knobf MT, Musanti R, Dorward J: Exercise and quality of life outcomes in patients with cancer. Semin Oncol Nurs 2007;23:285–296.
17.
Tawney KW, Tawney PJ, Kovach J: Disablement and rehabilitation in end-stage renal disease. Semin Dial 2003;16:447–452.
18.
Johansen KL, Chertow GM, Ng AV: Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 2000;57:2564–2570.
19.
Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM: Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr 2003;77:842–846.
20.
O’Hare AM, Tawney K, Bacchetti P, Johansen K: Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis 2003;41:447–454.
21.
Stack AG, Molony DA, Rives T, Tyson J, Murthy BV: Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis 2005;45:690–701.
22.
Adey D, Kumar R, McCarthy JT, Nair KS: Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab 2000;278:219–225.
23.
Graham KA, Reaich D, Channon SM, Downie S, Goodship TH: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 1997;8:632–637.
24.
Raj DS, Adeniyi O, Dominic EA: Amino acid repletion does not decrease muscle protein catabolism during hemodialysis. Am J Physiol Endcrinol Met 2007;292:1534–1542.
25.
Raj DS, Moseley P, Dominic EA: Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis. Kidney Int 2008;73:1054–1061.
26.
Ikizler TA, Pupim LB, Brouillette JR: Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 2002;282:107–116.
27.
Rajan V, Mitch WE: Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease. Biochim Biophys Acta 2008;1782:795–799.
28.
Evans K, Nasim Z, Brown J, Clapp E, Amin A, Yang B, Herbert TP, Bevington A: Inhibition of SNAT2 by metabolic acidosis enhances proteolysis in skeletal muscle. J Am Soc Nephrol 2008;19:2119–2129.
29.
Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK, Kent-Braun JA: Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney Int 2003;63:291–297.
30.
Kemp GJ, Crowe AV, Anijeet HK: Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo. Nephrol Dial Transplant 2004;19:1520–1527.
31.
Leaf DA, Kleinman MT, Deitrick RW: The effects of exercise on markers of lipid peroxidation in renal dialysis patients compared with control subjects. Am J Med Sci 2004;327:9–14.
32.
Hiatt WR, Koziol BJ, Shapiro JI, Brass EP: Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 1992;41:1613–1619.
33.
Sangkabutra T, Crankshaw DP, Schneider C: Impaired K+ regulation contributes to exercise limitation in end-stage renal failure. Kidney Int 2003;63:283–290.
34.
Sakkas GK, Ball D, Mercer TH, Sargeant AJ, Tolfrey K, Naish PF: Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dial Transplant 2003;18:2074–2081.
35.
Diesel W, Emms M, Knight BK: Morphologic features of the myopathy associated with chronic renal failure. Am J Kidney Dis 1993;22:677–684.
36.
Kaizu Y, Ohkawa S, Odamaki M: Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis 2003;42:295–302.
37.
Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA: Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007;71:146–152.
38.
Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE: IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 2009;20:604–612.
39.
Bradley JR, Anderson JR, Evans DB, Cowley AJ: Impaired nutritive skeletal muscle blood flow in patients with chronic renal failure. Clin Sci (Lond) 1990;79:239–245.
40.
Erslev AJ, Besarab A: Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 1997;51:622–630.
41.
Mayer G, Thum J, Graf H: Anaemia and reduced exercise capacity in patients on chronic haemodialysis. Clin Sci (Lond) 1989;76:265–268.
42.
Painter P, Moore GE: The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients. Adv Ren Replace Ther 1994;1:55–65.
43.
Suzuki M, Tsutsui M, Yokoyama A, Hirasawa Y: Normalization of hematocrit with recombinant human erythropoietin in chronic hemodialysis patients does not fully improve their exercise tolerance abilities. Artif Organs 1995;19:1258–1261.
44.
Cheema BSB, Fiatarone Singh MA: Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Nephrol 2005;25:352–364.
45.
Konstantinidou E, Koukouvou G, Kouidi E, Deligiannis A, Tourkantonis A: Exercise training in patients with end-stage renal disease on hemodialysis: comparison of three rehabilitation programs. J Rehabil Med 2002;34:40–45.
46.
Headley S, Germain M, Mailloux P: Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis 2002;40:355–364.
47.
Kouidi E, Albani M, Natsis K: The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant 1998;13:685–699.
48.
Storer TW, Casaburi R, Sawelson S, Kopple JD: Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant 2005;20:1429–1437.
49.
Deligiannis A, Kouidi E, Tassoulas E, Gigis P, Tourkantonis A, Coats A: Cardiac effects of exercise rehabilitation in hemodialysis patients. Int J Cardiol 1999;70:253–266.
50.
Kouidi EJ: Central and peripheral adaptations to physical training in patients with end-stage renal disease. Sports Med 2001;31:651–665.
51.
Anderson JE, Boivin MR Jr, Hatchett L: Effect of exercise training on interdialytic ambulatory and treatment-related blood pressure in hemodialysis patients. Ren Fail 2004;26:539–544.
52.
Boyce ML, Robergs RA, Avasthi PS: Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension, and renal function. Am J Kidney Dis 1997;30:180–192.
53.
Miller BW, Cress CL, Johnson ME, Nichols DH, Schnitzler MA: Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis 2002;39:828–833.
54.
Pechter U, Ots M, Mesikepp S, Zilmer K, Kullissaar T, Vihalemm T, Zilmer M, Maaroos, J: Beneficial effects of water-based exercise in patients with chronic kidney disease. Int J Rehab Res 2003;26:153–156.
55.
Painter PL, Nelson-Worel JN, Hill MM, Thornbery DR, Shelp WR, Harrington AR, Weinstein AB: Effects of exercise training during hemodialysis. Nephron 1986;43:87–92.
56.
Shalom R, Blumenthal JA, Williams RS, McMurray RG, Dennis VW: Feasibility and benefits of exercise training in patients on maintenance dialysis. Kidney Int 1984;25:958–963.
57.
Goldberg AP, Geltman EM, Gavin JR 3rd: Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients. Nephron 1986;42:311–316.
58.
Mustata S, Chan C, Lai V, Miller JA: Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol 2004;15:2713–2718.
59.
Conn VS, Hafdahl AR, Mehr DR, LeMaster JW, Brown SA, Nielsen PJ: Metabolic effects of interventions to increase exercise in adults with type 2 diabetes. Diabetologia 2007;50:913–921.
60.
Parsons TL, Toffelmire EB, King-VanVlack CE: Exercise training during hemodialysis improves dialysis efficacy and physical performance. Arch Phys Med Rehabil 2006;87:680–687.
61.
Oh-Park M, Fast A, Gopal S: Exercise for the dialyzed: aerobic and strength training during hemodialysis. Am J Phys Med Rehabil 2002;81:814–821.
62.
Kong CH, Tattersall JE, Greenwood RN, Farrington K: The effect of exercise during haemodialysis on solute removal. Nephrol Dial Transplant 1999;14:2927–2931.
63.
Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG: Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis 2004;43:85–89.
64.
Lott ME, Hogeman CS, Vickery L, Kunselman AR, Sinoway LI, MacLean DA: Effects of dynamic exercise on mean blood velocity and muscle interstitial metabolite responses in humans. Am J Physiol Heart Circ Physiol 2001;281:1734–1741.
65.
Rus RR, Ponikvar R, Kenda RB, Buturovic-Ponikvar J: Effect of local physical training on the forearm arteries and veins in patients with end-stage renal disease. Blood Purif 2003;21:389–394.
66.
Kouidi E, Iacovides A, Iordanidis P: Exercise renal rehabilitation program: psychosocial effects. Nephron 1997;77:152–158.
67.
Ouzouni S, Kouidi E, Sioulis A, Grekas D, Deligiannis A: Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin Rehabil 2009;23:53–63.
68.
Painter P, Carlson L, Carey S, Paul SM, Myll J: Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis 2000;35:482–492.
69.
Frey S, Mir AR, Lucas M: Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease. J Ren Nutr 1999;9:71–77.
70.
Painter P, Stewart AL, Carey S: Physical functioning: definitions, measurement, and expectations. Adv Ren Replace Ther 1999;6:110–123.
71.
Koufaki P, Mercer TH, Naish PF: Effects of exercise training on aerobic and functional capacity of end-stage renal disease patients. Clin Physiol Funct Imaging 2002;22:115–124.
72.
Johansen KL: Physical functioning and exercise capacity in patients on dialysis. Adv Ren Replace Ther 1999;6:141–148.
73.
Cheema B, O’Sullivan A, Chan M: Progressive resistance exercise training during hemodialysis: rationale and method of a randomized-controlled trial. Hemodial Int 2006;10:303–310.
74.
Mercer TH, Naish PF, Gleeson, NP, Wilcock JE, Crawford C: Development of a walking test for the assessment of functional capacity in non-anaemic maintenance dialysis patients. Nephrol Dial Transplant 1998;13:2023–2026.
75.
Kouidi E, Albani M, Konstantinos N: The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant 1998;13:685–699.
76.
Headley S, Germain M, Mailloux P: Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis 1998;40:355–364.
77.
Heiwe S, Clyne N, Tollback A, Borg K: Effects of regular resistance training on muscle histopathology and morphometry in elderly patients with chronic kidney disease. Am J Phys Med Rehabil 2005;84:865–874.
78.
Cheema B, Abas H, Smith B: Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the Progressive Exercise for Anabolism in Kidney Disease (PEAK) study. Am J Kidney Dis 2007;50:574–584.
79.
Chumlea WC: Anthropometric and body composition assessment in dialysis patients. Semin Dial 2004;17:466–470.
80.
Sakkas GK, Sargeant AJ, Mercer TH: Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training. Nephrol Dial Transplant 2003;18:1854–1861.
81.
National Collaborating Centre for Chronic Conditions: Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. London, Royal College of Physicians, 2008.
82.
Johansen KL: Exercise and dialysis. Hemodial Int 2008;12:290–300.
83.
Nelson ME, Rejeski WJ, Blair SN: Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1094–1105.
84.
Van Vilsteren MC, de Greef MH, Huisman RM: The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant 2005;20:141–146.
85.
Fuhrmann I, Krause R: Principles of exercising in patients with chronic kidney disease, on dialysis and for kidney transplant recipients. Clin Nephrol 2004;61(suppl 1):14–25.
86.
Kouidi E, Grekas D, Deligiannis A, Tourkantonis A: Outcomes of long-term exercise training in dialysis patients: comparison of two training programs. Clin Nephrol 2004;61(suppl 1):31–38.
87.
Banerjee A, Kong CH, Farrington K: The haemodynamic response to submaximal exercise during isovolaemic haemodialysis. Nephrol Dial Transplant 2004;19:1528–1532.
88.
Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T: Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized controlled trial. J Am Soc Nephrol 2006;7:2307–2314.
89.
Pupim LB, Flakoll PJ, Levenhagen D, Ikizler TA: Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 2004;286:589–597.
90.
Goldberg AP, Hagberg JM, Delmez JA, Heath GW, Harter HR: Exercise training improves abnormal lipid and carbohydrate metabolism in hemodialysis patients. Trans Am Soc Artif Intern Organs 1979;25:431–437.
91.
Steiner MC, Morgan MD: Enhancing physical performance in chronic obstructive pulmonary disease. Thorax 2001;56:73–77.
92.
Koufaki P, Nash PF, Mercer TH: Assessing the efficacy of exercise training in patients with chronic disease. Med Sci Sports Exerc 2000;34:1234–1241.
93.
Malagoni AM, Catizone, L, Mandini S, Soffritti S, Manfredini R, Boari B, Russo G, Basaglia N, Zamboni P, Manfredini F: Acute and long-term effects of an exercise program for dialysis patients prescribed in hospital and performed at home. J Nephrol 2008;21:871–878.
94.
Painter P: Exercise for patients with chronic disease: physician responsibility. Curr Sports Med Rep 2003;2:173–180.
95.
UK Renal Registry: 11th Annual Report 2008. Bristol, UK Renal Registry, 2008.
96.
Koopman R, van Loon LJC: Aging, exercise, and muscle protein metabolism. J Appl Physiol 2009;106:2040–2048.
97.
Stack AG, Murthy B: Exercise and limitations in physical activity levels among new dialysis patients in the United States: an epidemiologic study. Ann Epidemiol 2008;18:880–888.
98.
O’Hare A, Johansen K: Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001;12:2838–2847.
99.
Combe C, Albert JM, Bragg-Gresham JL, Andreucci VE, Disney A, Fukuhara S, Goodkin DA, Gillespie BW, Saito A, Jadoul M, Pisoni RL: The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2009;54:680–692.
100.
O’Hare AM, Hsu CY, Bacchetti P, Johansen KL: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002;13:497–503.
101.
European Association of Rehabilitation in Chronic Kidney Disease. http://www/renalrehab.com/indexeng.htm (accessed February 20, 2009).
102.
Grubeck-Loebenstein B, Vierhapper H, Waldhäusl W, Korn A, Graf M, Panzer S: Adrenergic mechanisms and blood pressure regulation in diabetes mellitus. Klin Wochenschr 1982;60:823–828.
103.
Heffernan KS, Jae SY, Vieira VJ, Iwamoto GA, Wilund KR, Woods JA, Fernhall B: C-reactive protein and cardiac vagal activity following resistance exercise training in young African-American and white men. Am J Physiol 2009;296:1098–1105.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.